Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Besse

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The Journal of Allergy and Clinical Immunology|May 7, 2018
Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen exchanger member 3 (NHE3) dysregulation and dilated intercellular spaces in patients with eosinophilic esophagitisChang Zeng, Simone Vanoni, David Wu, et al.
The Journal of Allergy and Clinical Immunology|November 19, 2019
Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site studyTetsuo Shoda, Ting Wen, Julie M Caldwell, et al.
Gastroenterology|January 27, 2022
Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site StudyTetsuo Shoda, Margaret H Collins, Mark Rochman, et al.
The Lancet. Gastroenterology & Hepatology|March 2, 2023
One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trialKara L Kliewer, Nirmala Gonsalves, Evan S Dellon, et al.
The Lancet. Gastroenterology & Hepatology|June 24, 2026
Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trialNirmala P Gonsalves, Evan S Dellon, Kara L Kliewer, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Journal of Allergy and Clinical Immunology|May 7, 2018
Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen exchanger member 3 (NHE3) dysregulation and dilated intercellular spaces in patients with eosinophilic esophagitisChang Zeng, Simone Vanoni, David Wu, et al.
The Journal of Allergy and Clinical Immunology|November 19, 2019
Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site studyTetsuo Shoda, Ting Wen, Julie M Caldwell, et al.
Gastroenterology|January 27, 2022
Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site StudyTetsuo Shoda, Margaret H Collins, Mark Rochman, et al.
The Lancet. Gastroenterology & Hepatology|March 2, 2023
One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trialKara L Kliewer, Nirmala Gonsalves, Evan S Dellon, et al.
The Lancet. Gastroenterology & Hepatology|June 24, 2026
Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trialNirmala P Gonsalves, Evan S Dellon, Kara L Kliewer, et al.
Pageof 2